logo en
  • Home
  • Manufacturing
    • Manufacturing
    • OEM Manufacturing
    • Quality Control
  • About the Factory
    • About the Factory
    • Our History
    • Management
    • Certificates
    • Partners
    • Licenses
    • Achievements
    • Special Evaluation of Labour Conditions
    • Videos
  • News
  • Products
  • Contacts
    • Contacts
    • Quality Claims
  • 简体中文(中国)
  • Russian (Russia)
  • You are here:  
  • Home /
  • News

News

The Medsintez Plant presented new import-substituting drugs at the exhibition-forum Healthcare of the Urals – 2024

Details
Published: 03 May 2024
From April 16 to April 19, the fifth International specialized exhibition-forum Healthcare of the Urals – 2024 was held at the Ekaterinburg-Expo IEC, where the Medsintez Plant, one of the key participants of this project, traditionally presented its products at the booth. This year, the focus was on equipping the medical system in the regions of Russia. The focus on import independence in the current conditions also remains one of the key ones. 160 manufacturers and suppliers of medical products from 34 cities of Russia, which presented over a thousand pieces of various equipment, took part in the event.

Read more ...

20 years on guard of the drug safety of the Russian Federation

Details
Published: 13 March 2024
At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
 

Read more ...

The Medsintez Plant has launched a full-cycle production of hypoglycemic drugs for treating type II diabetes mellitus

Details
Published: 22 January 2024
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.

Read more ...

Triazavirin is the first in the fight against COVID-19

Details
Published: 27 December 2023

On October 26, 2023, a new indication was added to the instructions for medical use of the Triazavirin drug – now the drug can also be used for the prevention of COVID-19.

Triazavirin is the only direct-acting antiviral drug approved for the prevention of COVID-19 approved by the Ministry of Health of the Russian Federation.

Read more ...

The latest biotechnological developments of the Medsintez are presented at the international forum Russian Healthcare Week - 2023

Details
Published: 13 December 2023
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week - 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.

Read more ...

Page 8 of 23

  • Start
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next
  • End

Privacy Policy

Copyright © 2003-2026

+7 (34370) 2-50-61

+7 (34370) 2-54-95

Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130

Contacts

Для использования сайта дайте согласие на обработку файлов cookie и ваших персональных данных, в т.ч. с помощью сервиса «Яндекс Метрика», в соответствии с Политикой по обработке персональных данных путем нажатия на кнопку «Ок»